Implant infection after two-stage sacral nerve stimulator placement

International Urogynecology Journal

Volumn 18, Issue 12, 2007, Pages 1477-1480

  Washington, Blair B ^a   Hines, Brian J ^a  

^a STAMFORD HOSPITAL   (United States)

Author keywords

Infection; Interstim; Sacralim plant

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CIPROFLOXACIN; LEVOFLOXACIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEVICE INFECTION; DEVICE REMOVAL; DISEASE RESISTANCE; FEMALE; HUMAN; INFECTION RISK; NERVE STIMULATION; PATHOGENESIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REOPERATION; STAGING; STAPHYLOCOCCUS AUREUS; URINARY FREQUENCY; URINE INCONTINENCE; URINE RETENTION; WOUND INFECTION;

EID: 35948977774     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-007-0386-9     Document Type: Article

References (5)

1. Jonas U, Fowler CJ, Chancellor MB et al (1998) Efficacy of sacral nerve stimulation for urinary retention: Results 18 months after implantation. J Urol 165:15-19
2. Hijaz A, Vasavada S (2005) Complications and troubleshooting of the sacral neuromodulation therapy. Urol Clin North Am 32:65-69
3. Abrams P, Blaivas JG, Fowler CJ et al (2003) The role of neuromodulation in the management of urinary urge incontinence. BJU Int 91:355-359
4. Pannek J, Grigoleit U, Hinkel A (2005) Bacterial contamination of test stimulation leads during percutaneous nerve stimulation. Urology 65:1096-1098
5. Lauwers S, de Smet F (1998) Surgical site infections. Acta Clin Belg 53:303-310